Chordia Therapeutics (TSE:190A) EPS (Basic) : 円-10.25 (TTM As of Aug. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Chordia Therapeutics EPS (Basic)?

Chordia Therapeutics's basic earnings per share (Basic EPS) for the three months ended in Aug. 2024 was 円-10.25. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Aug. 2024 was 円-10.25.

Chordia Therapeutics's EPS (Diluted) for the three months ended in Aug. 2024 was 円-10.25. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Aug. 2024 was 円-10.25.

Chordia Therapeutics's EPS without NRI for the three months ended in Aug. 2024 was 円-10.25. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Aug. 2024 was -10.25.

During the past 12 months, Chordia Therapeutics's average EPS without NRIGrowth Rate was -885.60% per year. During the past 3 years, the average EPS without NRI Growth Rate was -57.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 4 years, Chordia Therapeutics's highest 3-Year average EPS without NRI Growth Rate was -57.00% per year. The lowest was -57.00% per year. And the median was -57.00% per year.

Chordia Therapeutics EPS (Basic) Historical Data

The historical data trend for Chordia Therapeutics's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordia Therapeutics EPS (Basic) Chart

Chordia Therapeutics Annual Data

Trend

Aug21

Aug22

Aug23

Aug24

EPS (Basic)

-9.34

-31.52

3.96

-31.11

Chordia Therapeutics Quarterly Data
	Aug21	Aug22	May23	Aug23	May24	Aug24
EPS (Basic)	Get a 7-Day Free Trial			-	-	-9.30	-	-10.25

Chordia Therapeutics EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Chordia Therapeutics's Basic EPS for the fiscal year that ended in Aug. 2024 is calculated as

Basic EPS (A: Aug. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-1827.127	-	0)	/	58.729
	=	-31.11

Chordia Therapeutics's Basic EPS for the quarter that ended in Aug. 2024 is calculated as

Basic EPS (Q: Aug. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-649.648	-	0)	/	65.587
	=	-9.91

EPS (Basic) for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-10.25

Chordia Therapeutics (TSE:190A) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Chordia Therapeutics EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Chordia Therapeutics's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Chordia Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chordia Therapeutics Inc (TSE:190A) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-26-1 Muraoka-Higashi, Kanagawa, Fujisawa, JPN, 251-0012

Website

https://www.chordiatherapeutics.com

Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.

Chordia Therapeutics Headlines

No Headlines